Form 4: AbCellera Biologics Director Buys Shares
Insider Transaction (Form 4)
Michael R Hayden, a Director of AbCellera Biologics Inc., purchased 53,613 shares of common stock on August 24, 2026 for $10.64 per share.
Summary
- Open-market purchase: acquired 53,613 Common Shares at $10.64 ($570,442) on August 24, 2026; holds 1,373,397 after (Indirect).
Sentiment
Score: 8
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $570,442, committing personal capital to the stock.
Insider Transactions
Michael R Hayden — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market purchase | Common Shares | 53,613 | $11 | $570.4K | 1,373,397 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market purchase (53,613 shares) |
Keywords
insider transaction, Form 4, ABCL, AbCellera Biologics Inc., bullish, Michael R Hayden
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.